T1	Intervention 440 580	blinded abacavir-lamivudine (ABC/3TC) or tenofovir DF-emtricitabine (TDF/FTC) with open-label efavirenz (EFV) or atazanavir-ritonavir (ATV/r
T2	Intervention 583 697	All participants underwent dual-energy absorptiometry (DXA) and abdominal computed tomography for body composition
